SCHEMBL5269253

SCHEMBL5269253

Nc1cccc(O)c1CNc1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 2/20 0.42
RECQL P46063 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ALOX12 P18054 2/20 0.42
KDM4E B2RXH2 2/20 0.42
USP2 O75604 1/20 0.42
MPI P34949 1/20 0.42
MEN1 O00255 3/20 0.41
RAB9A P51151 3/20 0.41
THRB P10828 1/20 0.41
PKM P14618 1/20 0.41
BLM P54132 1/20 0.41
CASP6 P55212 1/20 0.41
POLB P06746 1/20 0.40
PLEC Q15149 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272425 0.87 MAOA (0.42) MAPTALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL5272368 0.87 BCHE (0.47) MAPTALDH1A1KMT2ALMNARECQL
SCHEMBL5271190 0.86 MAPT (0.37) MAPTALDH1A1KMT2AALOX12MEN1
SCHEMBL5270890 0.85 HIF1A (0.44) MAPTALDH1A1ALOX12MAOBCA12
SCHEMBL5272106 0.84 KDM4E (0.46) MAPTALDH1A1KMT2ALMNATDP1
SCHEMBL5274977 0.84 AGER (0.47) MAPTALDH1A1KMT2ARECQLTDP1
SCHEMBL5272301 0.84 MAPT (0.57) MAPTALDH1A1KMT2ATDP1L3MBTL1
SCHEMBL5270148 0.84 ACHE (0.42) MAPTALDH1A1KMT2ARECQLL3MBTL1
SCHEMBL5272458 0.83 BRD4 (0.45) MAPTALDH1A1KMT2AMEN1RAB9A
SCHEMBL5269215 0.81 ARG1 (0.41) MAPTALDH1A1KMT2AALOX12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846361-A2 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-10-24 EP claimed
US-20070022546-A1 3-Amino-2-aminomethylphenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-01 US claimed
WO-2006086374-A2 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2006-08-17 WO claimed
EP-1846361-A2 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-10-24 EP disclosed
US-20070022546-A1 3-Amino-2-aminomethylphenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-01 US disclosed
WO-2006086374-A2 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2006-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070022546-A1 3-Amino-2-aminomethylphenol derivatives and colorants comprising these compounds KRT18, COL2A1, COL1A1 MAPT 317/4885ALDH1A1 402/4885KMT2A 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.